Scientific Reports · 2017 · 130 citations · 42 references
MedicineCancer BiologyOncologyBreast OncologyMetastasisMolecular OncologyBreast Cancer ImagingCancer ProgressionMalignant NeoplasmsMetastatic Breast CancerTumor ImagingCancer Metastasis MechanismsIn Vitro Bioluminescence ImagingMetastatic Breast Cancer BiologyMetastatic Potential AssessmentMicro-computed Tomography EvaluationTomographic Bioluminescence ImagingTransgenic Mouse Cancer ModelsVisceral Metastases
Implantation of reporter-labeled tumor cells in an immunocompetent host involves a risk of their immune elimination. We have studied this effect in a mouse model of breast cancer after the orthotopic implantation of mammary gland adenocarcinoma 4T1 cells genetically labelled with luciferase (Luc). Mice were implanted with 4T1 cells and two derivative Luc-expressing clones 4T1luc2 and 4T1luc2D6 exhibiting equal in vitro growth rates. In vivo, the daughter 4T1luc2 clone exhibited nearly the same, and 4T1luc2D6, a lower growth rate than the parental cells. The metastatic potential of 4T1 variants was assessed by magnetic resonance, bioluminescent imaging, micro-computed tomography, and densitometry which detected 100-μm metastases in multiple organs and bones at the early stage of their development. After 3-4 weeks, 4T1 generated 11.4 ± 2.1, 4T1luc2D6, 4.5 ± 0.6; and 4T1luc2, <1 metastases per mouse, locations restricted to lungs and regional lymph nodes. Mice bearing Luc-expressing tumors developed IFN-γ response to the dominant CTL epitope of Luc. Induced by intradermal DNA-immunization, such response protected mice from the establishment of 4T1luc2-tumors. Our data show that natural or induced cellular response against the reporter restricts growth and metastatic activity of the reporter-labelled tumor cells. Such cells represent a powerful instrument for improving immunization technique for cancer vaccine applications.
42
Metastatic Behavior of Breast Cancer Subtypes
Hagen F. Kennecke, Rinat Yerushalmi, Ryan Woods et al. · Journal of Clinical Oncology · 2010 · 2.3K citations · Full text
Medicine, Cancer Biology, Oncology +14
Beth A. Pulaski, Suzanne Ostrand‐Rosenberg · Current Protocols in Immunology · 2000 · 910 citations
flowCore: a Bioconductor package for high throughput flow cytometry
Florian Hahne, Nolwenn Le Meur, Ryan R. Brinkman et al. · BMC Bioinformatics · 2009 · 651 citations · Full text